AstraZeneca PLC (OTCMKTS:AZNCF – Get Free Report) shares traded up 0.1% during mid-day trading on Monday . The stock traded as high as $168.56 and last traded at $163.99. 2,121 shares were traded during mid-day trading, a decline of 28% from the average session volume of 2,943 shares. The stock had previously closed at $163.75.
AstraZeneca Price Performance
The company’s 50-day moving average is $161.41 and its 200-day moving average is $149.06.
About AstraZeneca
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.
Featured Articles
- Five stocks we like better than AstraZeneca
- Consumer Staples Stocks, Explained
- Growth Picks: 3 Low-Cost Stocks That Could Double in Value
- How to Choose Top Rated Stocks
- Are These 3 Beaten-Down Stocks Ready to Rebound?
- 3 Small Caps With Big Return Potential
- Does the Trump-Induced Quantum Stock Rally Have Legs?
Receive News & Ratings for AstraZeneca Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca and related companies with MarketBeat.com's FREE daily email newsletter.
